AirSculpt Technologies Surges Amid Positive Market Sentiment
AirSculpt Technologies Inc. saw a significant price increase of 41.08% as it crossed above its 5-day SMA, reflecting strong investor interest. Amid a broader market rally, with the Nasdaq-100 up 1.16% and the S&P 500 up 0.98%, AirSculpt's performance aligns with the positive market sentiment that is attracting investors to tech stocks. This surge indicates a growing confidence in the company's prospects, potentially driven by favorable market conditions.
Trade with 70% Backtested Accuracy
Analyst Views on AIRS
About AIRS
About the author
NASDAQ 100 Pre-Market Indicator Rises Significantly
- Market Indicator Surge: The NASDAQ 100 Pre-Market Indicator rises by 266.97 points to 24,647.7, indicating a positive shift in market sentiment that may attract more investors to tech stocks.
- Active Stock Performance: CytomX Therapeutics, Inc. (CTMX) increases by $2.34 to $7.02 with a trading volume of 27,793,236 shares, reflecting optimistic short-term prospects for the company.
- ETF Trading Dynamics: ProShares UltraPro QQQ (TQQQ) climbs $1.46 to $47.39 with 6,584,506 shares traded, representing a 170.8% increase from its 52-week low, showcasing strong investor interest in tech stocks.
- Earnings Forecast Revisions: Circle Internet Group, Inc. (CRCL) rises $5.795 to $121.18, with an expected EPS of $0.22 for the fiscal quarter ending September 2026, indicating market confidence in its future profitability.
Zeta Global Surpasses Quarterly Earnings Expectations
- Earnings Beat: Zeta Global Holdings reported earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.23, reflecting a 40% increase from last year's $0.20, indicating a significant improvement in profitability.
- Significant Revenue Growth: The company posted revenues of $394.64 million for the quarter, surpassing the Zacks Consensus Estimate of $380 million and marking a 25.4% increase from $314.67 million a year ago, demonstrating strong market demand.
- Underperformance in Market: Despite exceeding earnings expectations, Zeta's stock has declined approximately 26.4% since the beginning of the year, compared to a 0.1% drop in the S&P 500, reflecting investor concerns about the company's future performance.
- Cautious Outlook: With a current Zacks Rank of 3 (Hold), investors are cautious about earnings expectations for the upcoming quarters, especially given the Technology Services industry's ranking in the bottom 38%.
Friday's Underperforming Sectors: Construction, Healthcare, and Medical Professionals
Market Performance: Hospital and medical practitioners' shares are down approximately 1.7% on Friday, with Agilon Health and AirSculpt Technologies leading the decline at 9% and 8.3%, respectively.
Sector Laggards: The construction sector, along with hospital and medical practitioners, is identified as a laggard in the market on Friday.
Video Coverage: A video segment highlights the performance of these sectors, focusing on the laggards in the market.
Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Three Health Care Stocks That Could Revitalize Your Portfolio This November
Oversold Stocks in Health Care: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Inotiv Inc Performance: Inotiv Inc reported strong contract awards and anticipates fourth-quarter revenue between $137.5 million and $138.5 million, despite its stock falling 38% recently, with an RSI of 26.7.
Airsculpt Technologies Update: Airsculpt Technologies faced disappointing third-quarter results and lowered its FY25 revenue outlook, leading to a 60% stock drop over the past month, with an RSI of 29.3.
Neuronetics Sales Guidance: Neuronetics cut its FY2025 sales guidance, resulting in a 40% decline in stock value over the past month, and it currently has an RSI of 23.9.
AirSculpt Technologies Names Mike Doyle as Non-Executive Board Chairman
Appointment of New Chairman: AirSculpt Technologies has appointed Mike Doyle as the Non-Executive Chairman of its Board of Directors, bringing over 30 years of experience in the multi-center healthcare sector.
Leadership Experience: Doyle has a strong background in scaling healthcare organizations, having previously served as CEO of Surgery Partners and held leadership roles in various healthcare boards.
CEO's Statement: Yogi Jashnani, CEO of AirSculpt, expressed enthusiasm about Doyle's appointment, highlighting his experience in partnering with surgeons and developing new service lines.
About AirSculpt: AirSculpt offers a next-generation body contouring treatment that is minimally invasive, focusing on comfort and precision, with quick healing and minimal bruising.
Exclusive: Cosmetic Surgeon Lists His Expansive Florida Mansion for $200 Million
South Florida Real Estate Boom: South Florida has seen a surge in $100 million home sales, attracting high-end listings in the ultrahigh market.
Record-Setting Mansion Listing: A nearly-completed mansion on Indian Creek is set to hit the market for $200 million, potentially becoming the most expensive sale in Miami-Dade County history.
NASDAQ 100 Pre-Market Indicator Rises Significantly
- Market Indicator Surge: The NASDAQ 100 Pre-Market Indicator rises by 266.97 points to 24,647.7, indicating a positive shift in market sentiment that may attract more investors to tech stocks.
- Active Stock Performance: CytomX Therapeutics, Inc. (CTMX) increases by $2.34 to $7.02 with a trading volume of 27,793,236 shares, reflecting optimistic short-term prospects for the company.
- ETF Trading Dynamics: ProShares UltraPro QQQ (TQQQ) climbs $1.46 to $47.39 with 6,584,506 shares traded, representing a 170.8% increase from its 52-week low, showcasing strong investor interest in tech stocks.
- Earnings Forecast Revisions: Circle Internet Group, Inc. (CRCL) rises $5.795 to $121.18, with an expected EPS of $0.22 for the fiscal quarter ending September 2026, indicating market confidence in its future profitability.
Zeta Global Surpasses Quarterly Earnings Expectations
- Earnings Beat: Zeta Global Holdings reported earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.23, reflecting a 40% increase from last year's $0.20, indicating a significant improvement in profitability.
- Significant Revenue Growth: The company posted revenues of $394.64 million for the quarter, surpassing the Zacks Consensus Estimate of $380 million and marking a 25.4% increase from $314.67 million a year ago, demonstrating strong market demand.
- Underperformance in Market: Despite exceeding earnings expectations, Zeta's stock has declined approximately 26.4% since the beginning of the year, compared to a 0.1% drop in the S&P 500, reflecting investor concerns about the company's future performance.
- Cautious Outlook: With a current Zacks Rank of 3 (Hold), investors are cautious about earnings expectations for the upcoming quarters, especially given the Technology Services industry's ranking in the bottom 38%.
Friday's Underperforming Sectors: Construction, Healthcare, and Medical Professionals
Market Performance: Hospital and medical practitioners' shares are down approximately 1.7% on Friday, with Agilon Health and AirSculpt Technologies leading the decline at 9% and 8.3%, respectively.
Sector Laggards: The construction sector, along with hospital and medical practitioners, is identified as a laggard in the market on Friday.
Video Coverage: A video segment highlights the performance of these sectors, focusing on the laggards in the market.
Author's Perspective: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Three Health Care Stocks That Could Revitalize Your Portfolio This November
Oversold Stocks in Health Care: The health care sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with a Relative Strength Index (RSI) below 30.
Inotiv Inc Performance: Inotiv Inc reported strong contract awards and anticipates fourth-quarter revenue between $137.5 million and $138.5 million, despite its stock falling 38% recently, with an RSI of 26.7.
Airsculpt Technologies Update: Airsculpt Technologies faced disappointing third-quarter results and lowered its FY25 revenue outlook, leading to a 60% stock drop over the past month, with an RSI of 29.3.
Neuronetics Sales Guidance: Neuronetics cut its FY2025 sales guidance, resulting in a 40% decline in stock value over the past month, and it currently has an RSI of 23.9.
AirSculpt Technologies Names Mike Doyle as Non-Executive Board Chairman
Appointment of New Chairman: AirSculpt Technologies has appointed Mike Doyle as the Non-Executive Chairman of its Board of Directors, bringing over 30 years of experience in the multi-center healthcare sector.
Leadership Experience: Doyle has a strong background in scaling healthcare organizations, having previously served as CEO of Surgery Partners and held leadership roles in various healthcare boards.
CEO's Statement: Yogi Jashnani, CEO of AirSculpt, expressed enthusiasm about Doyle's appointment, highlighting his experience in partnering with surgeons and developing new service lines.
About AirSculpt: AirSculpt offers a next-generation body contouring treatment that is minimally invasive, focusing on comfort and precision, with quick healing and minimal bruising.
Exclusive: Cosmetic Surgeon Lists His Expansive Florida Mansion for $200 Million
South Florida Real Estate Boom: South Florida has seen a surge in $100 million home sales, attracting high-end listings in the ultrahigh market.
Record-Setting Mansion Listing: A nearly-completed mansion on Indian Creek is set to hit the market for $200 million, potentially becoming the most expensive sale in Miami-Dade County history.
